GHK-Cu
Melanotan II
For research use only
Melanotan II
A cyclic alpha-MSH analogue, a non-selective melanocortin receptor agonist. Seven amino acids in a cyclic structure, supplied as a lyophilised powder.
1 ks
25.00 €
3+ ksza kus
20.00 €
Total
25.00 €
Dispatch on business days. Lyophilised powder tolerates normal transit times without cooling — storage after delivery is covered in the tab below.
Discreet packaging. Neutral outer packaging with no indication of the contents or the sender.
What Melanotan II is
- A synthetic cyclic heptapeptide, an analogue of alpha-melanocyte-stimulating hormone (alpha-MSH).
- The cyclic structure makes it more resistant to degradation than linear alpha-MSH.
- It is **non-selective** — it acts on several melanocortin receptors including MC1R, MC3R, MC4R and MC5R. That is the main difference from Melanotan I.
Documented mechanism
- MC1R agonism is associated in the literature with the stimulation of melanogenesis.
- Action at MC4R is studied in connection with the regulation of food intake and with sexual function — it is precisely this lack of selectivity that accounts for the broader range of effects described.
- Engagement of MC3R and MC5R is less well studied.
Areas of research
- Melanogenesis and pigmentation.
- Melanocortin receptor signalling.
- Regulation of food intake through MC4R.
State of knowledge
Melanotan II never completed clinical development. The published literature is
predominantly from preclinical models and case reports, not from controlled
studies. The literature also describes adverse events associated with its
non-selective action and with uncontrolled use.
Regulatory notice
Melanotan II is not authorised as a medicine in any jurisdiction known to us,
and several medicines agencies have publicly warned against its use in humans.
This item is a **reference standard intended strictly for laboratory and
research use**. It is neither a medicine nor a cosmetic, it must not be used for
administration to humans or animals, and we provide no dosing or health advice
with it.
The efficacy and safety of administering this substance to humans are not sufficiently established clinically. The information given here is solely a summary of published research findings, predominantly from laboratory and animal models. It constitutes neither a health claim nor a recommendation for use in humans. The product is intended strictly for research purposes and is not a medicine.
Handling and documentation
- Name
- Melanotan II
- Form
- Lyophilised powder
- Category
- Beauty
| Strength | Cat. no. | Batch | Purity | 1 unit | 3+ units |
|---|---|---|---|---|---|
| 10 mg | UP-MT2-10 | batch M2-2406 | 99.21 % | 25 € | 20 € |
- Solvent
- Bacteriostatic water (Bac Water) — available as a separate item in the Supporting products category.
- Procedure
- Run the solvent down the wall of the vial, not directly onto the lyophilised powder. Do not shake the vial — swirl gently until fully dissolved.
- Note
- We provide no dosing protocols and no recommendations for use in humans. What is given here are laboratory handling procedures only.
- Lyophilised (unreconstituted)
- −20 °C, in the dark, in the original packaging.
- After reconstitution
- 2–8 °C, protected from light. Do not refreeze repeatedly.
- Transport
- Neutral packaging, no cold chain. A short-term rise in temperature during transit has no material effect on the lyophilised powder.
- Batch
- M2-2406
- Purity
- 99.21 %
- Identity
- Confirmed by mass spectrometry
- Document
- Download COA (PDF) →
You save 15.00 € on 3 units.
Related items
GHK-Cu
BPC-157
BPC-157 + TB-500
BPC-157 + TB-500
10 · 20 mg In stock2 strengths available1 unitfrom 46.00 €
3+ unitseachfrom 44.00 €
Melanotan I
Melanotan II 10 mg
25.00 €